JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on November 21, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/48/45015    most recent
M107054200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mollard, C.
Right arrow Articles by Roberts, G. C .K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mollard, C.
Right arrow Articles by Roberts, G. C .K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print September 19, 2001
J. Biol. Chem, 10.1074/jbc.M107054200
Submitted on July 25, 2001
Revised on September 17, 2001
Accepted on September 19, 2001

Thiomandelic acid, a broad-spectrum inhibitor of zinc beta-olactamases: kinetic and spectroscopic studies

Claire Mollard, Catherine Moali, Cyril Papamicael, Christian Damblon, Sandrine Vessilier, Gianfranco Amicosante, Christopher J. Schofield, Moreno Galleni, Jean-Marie Frere, and Gordon C .K. Roberts

Department of Biochemistry, University of Leicester, Leicester LE1 7RH

Corresponding Author: gcr{at}le.ac.uk

Resistance to beta-lactam antibiotics mediated by metallo-beta-lactamases is an increasingly worrying clinical problem. Candidate inhibitors include mercaptocarboxylic acids, and we report studies of a simple such compound, thiomandelic acid. A series of 35 analogues were synthesised and examined as metallo-beta-lactamase inhibitors. The Ki values (B. cereus enzyme) are 0.09microM for R-thiomandelic acid and 1.28microM for the S-isomer. Structure-activity relationships show that the thiol is essential for activity and the carboxylate increases potency; the affinity is greatest when these groups are close together. Thioesters of thiomandelic acid are substrates for the enzyme, liberating thiomandelic acid, suggesting a starting-point for the design of 'pro-drugs'. Importantly, thiomandelic acid is a broad-spectrum inhibitor of metallo-beta-lactamases, with a sub-micromolar Ki for all nine enzymes tested, except the Aeromonas hydrophila enzyme; such a wide spectrum of activity is unprecedented. The binding of thiomandelic acid to the B. cereus enzyme was studied by NMR; the results are consistent with the idea that the inhibitor thiol binds to both zinc ions, while its carboxylate binds to Arg91. Amide chemical shift perturbations for residues 30-40 (the beta3-beta4 loop) suggest that this small inhibitor induces a movement of this loop of the kind seen for other larger inhibitors.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.